These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15765117)

  • 41. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
    Torjemane L; Ladeb S; Ben Othman T; Abdelkefi A; Lakhal A; Ben Abdeladhim A
    Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behavioral and emotional problems in children with sickle cell disease and healthy siblings: Multiple informants, multiple measures.
    Hijmans CT; Grootenhuis MA; Oosterlaan J; Last BF; Heijboer H; Peters M; Fijnvandraat K
    Pediatr Blood Cancer; 2009 Dec; 53(7):1277-83. PubMed ID: 19731327
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor.
    Chim CS; Lie AK; Liang R; Au WY; Kwong YL
    Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The case of A.R.: the ethics of sibling donor bone marrow transplantation revisited.
    Opel DJ; Diekema DS
    J Clin Ethics; 2006; 17(3):207-19. PubMed ID: 17186933
    [No Abstract]   [Full Text] [Related]  

  • 45. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
    Gaynon PS; Harris RE; Altman AJ; Bostrom BC; Breneman JC; Hawks R; Steele D; Zipf T; Stram DO; Villaluna D; Trigg ME
    J Clin Oncol; 2006 Jul; 24(19):3150-6. PubMed ID: 16717292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful reduced-intensity bone marrow transplantation in a patient with bone marrow failure associated with Seckel syndrome.
    Rayburg M; Davies SM; Mehta PA; Crockett M; Jodele S
    Br J Haematol; 2008 Aug; 142(4):675-6. PubMed ID: 18503579
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of the gel test to follow up chimerism in ABO mismatched bone marrow transplantation patient: a case report.
    Lumkul R; Nathalang O; Arnutti P; Janyatham A; Torcharus K; Krutvecheo T; Sriphaisal T
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S311-6. PubMed ID: 16858974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenotypic cure 6 years after bone marrow transplantation in a beta-thalassemia patient.
    Berger-Achituv S; Rothschild M; Naparstek E; Wolach B
    Am J Hematol; 2009 Jun; 84(6):373-5. PubMed ID: 19415725
    [No Abstract]   [Full Text] [Related]  

  • 49. A novel method of bone marrow transplantation (BMT) for intractable autoimmune diseases.
    Ikehara S
    J Autoimmun; 2008 May; 30(3):108-15. PubMed ID: 18249091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
    Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.
    Resnick IB; Aker M; Tsirigotis P; Shapira MY; Abdul-Hai A; Bitan M; Gesundheit B; Amar A; Ackerstein A; Samuel S; Slavin S; Or R
    Bone Marrow Transplant; 2007 Nov; 40(10):957-64. PubMed ID: 17846604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone marrow transplantation for beta-thalassemia.
    Giardini C; Lucarelli G
    Hematol Oncol Clin North Am; 1999 Oct; 13(5):1059-64, viii. PubMed ID: 10553261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children].
    Hao WG; Sun X; Liu S; Zhao Z; Chen ZX
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):546-8. PubMed ID: 19650987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of transplantation with related- and unrelated-donor stem cells in children with severe thalassemia.
    Hongeng S; Pakakasama S; Chuansumrit A; Sirachainan N; Kitpoka P; Udomsubpayakul U; Ungkanont A; Jootar S
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):683-7. PubMed ID: 16737942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Supporting siblings through the pediatric bone marrow transplant trajectory: perspectives of siblings of bone marrow transplant recipients.
    Wilkins KL; Woodgate RL
    Cancer Nurs; 2007; 30(5):E29-34. PubMed ID: 17876175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bone mineral density in children with thalassaemia major: determining factors and effects of bone marrow transplantation.
    Leung TF; Hung EC; Lam CW; Li CK; Chu Y; Chik KW; Shing MM; Lee V; Yuen PM
    Bone Marrow Transplant; 2005 Aug; 36(4):331-6. PubMed ID: 15968288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bone marrow transplantation in thalassemia.
    Lucarelli G; Giardini C; Angelucci E
    Cancer Treat Res; 1997; 77():305-15. PubMed ID: 9071508
    [No Abstract]   [Full Text] [Related]  

  • 58. Pregnancy in patients treated for beta thalassemia major in two centers (Ali Asghar Children's Hospital and Thalassemia Clinic): outcome for mothers and newborn infants.
    Ansari S; Azarkeivan A; Tabaroki A
    Pediatr Hematol Oncol; 2006; 23(1):33-7. PubMed ID: 16326410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Eur J Haematol; 2007 Apr; 78(4):338-46. PubMed ID: 17378893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The crux of the log rank test. Re: Locasciulli A, Oneto R, Bacigalupo A, Socie G, Korthof E, Bekassy A, Schrezenmeier H, Passweg J, Fuhrer M. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation. Haematologica 2007; 92:11-8.
    Linden T; Gerss J; Jürgens H
    Haematologica; 2007 Dec; 92(12):e122. PubMed ID: 18055974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.